| Size | Price | Stock | Qty |
|---|---|---|---|
| 10mg |
|
||
| Other Sizes |
|
| Additional Infomation |
L-alanyl-L-glutamic acid is a dipeptide consisting of L-glutamic acid having an L-alanyl attached to its alpha-amino group
L-Alanyl-L-Glutamate is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). |
|---|
| Exact Mass |
218.09
|
|---|---|
| CAS # |
13187-90-1
|
| PubChem CID |
128841
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.4±0.1 g/cm3
|
| Boiling Point |
520.5±50.0 °C at 760 mmHg
|
| Flash Point |
268.6±30.1 °C
|
| Vapour Pressure |
0.0±2.9 mmHg at 25°C
|
| Index of Refraction |
1.528
|
| LogP |
-2.33
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
15
|
| Complexity |
266
|
| Defined Atom Stereocenter Count |
2
|
| SMILES |
C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)N
|
| InChi Key |
VYZAGTDAHUIRQA-WHFBIAKZSA-N
|
| InChi Code |
InChI=1S/C8H14N2O5/c1-4(9)7(13)10-5(8(14)15)2-3-6(11)12/h4-5H,2-3,9H2,1H3,(H,10,13)(H,11,12)(H,14,15)/t4-,5-/m0/s1
|
| Chemical Name |
(2S)-2-[[(2S)-2-aminopropanoyl]amino]pentanedioic acid
|
| Synonyms |
Alanine glutamate L-Glutamic acid, N-L-alanyl- Alanylglutamic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~250 mg/mL (~1145.69 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (458.27 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
| NCT Number | Recruitment | interventions | Conditions | Sponsor/Collaborators | Start Date | Phases |
| NCT03493178 | RECRUITING | Dietary Supplement: Glycine Dietary Supplement: N-acetylcysteine (NAC) Dietary Supplement: Alanine |
Mild Cognitive Impairment | Baylor College of Medicine | 2018-04-14 | Early Phase 1 |
| NCT03180775 | UNKNOWN STATUS | Other: Cellulose (control) Dietary Supplement: Glycine Dietary Supplement: Alanine |
Atherosclerosis Diet Modification Serum; Disease |
Rambam Health Care Campus | 2017-07-01 | Not Applicable |
| NCT00005767 | UNKNOWN STATUS | Kidney Diseases | National Center for Research Resources (NCRR) | |||
| NCT01048905 | COMPLETEDWITH RESULTS | Drug: L-Glutamine | Pulmonary Hypertension Sickle Cell Disease Thalassemia |
UCSF Benioff Children's Hospital Oakland | 2009-03 | Phase 2 |
| NCT06059911 | ACTIVE, NOT RECRUITING | Dietary Supplement: Multi-ingredient dietary supplement (caffeine, creatine monohydrate, β-alanine, citrulline malate, BCAA) Dietary Supplement: Placebo dietary supplement (97% maltodextrin) |
Sport Performance | Athanasios Z. Jamurtas | 2022-06-15 | Not Applicable |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
